Neogenomics (NEO) PT Lowered to $16 at Morgan Stanley
Tweet
Share
E-mailGet Alerts NEO Hot Sheet
Price: $16.16 +1.38%
Rating Summary:
14 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 20
Rating Summary:
14 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 20
Join SI Premium – FREE
Morgan Stanley analyst Tejas Savant lowered the price target on Neogenomics (NASDAQ: NEO) to $16.00 (from $18.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- argenx SE (ARGX) PT Raised to $1,353 at TD Cowen
- JD Health International Inc (6618:HK) PT Lowered to HK$60 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
